Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06264180
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2024-01-29
Brief Title:
VO and Nivolumab vs Physicians Choice in Advanced Melanoma That Progressed on Anti-PD-1 Anti-CTLA-4 Drugs IGNYTE-3
Sponsor:
Replimune Inc
Organization:
Replimune Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Melanoma |
Keywords: